Giant Biogene Holding Co Ltd
HKEX:2367
Wall Street
Price Targets
Price Targets Summary
Giant Biogene Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for Giant Biogene Holding Co Ltd is 86 HKD with a low forecast of 57.15 HKD and a high forecast of 105 HKD.
Operating Income
Forecast
Operating Income Estimate
Giant Biogene Holding Co Ltd
For the last 4 years the compound annual growth rate for Giant Biogene Holding Co Ltd's operating income is 30%. The projected CAGR for the next 3 years is 25%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Giant Biogene Holding Co Ltd's stock price target?
Price Target
86
HKD
According to Wall Street analysts, the average 1-year price target for Giant Biogene Holding Co Ltd is 86 HKD with a low forecast of 57.15 HKD and a high forecast of 105 HKD.
What is Giant Biogene Holding Co Ltd's Revenue forecast?
Projected CAGR
27%
For the last 4 years the compound annual growth rate for Giant Biogene Holding Co Ltd's revenue is 47%. The projected CAGR for the next 3 years is 27%.
What is Giant Biogene Holding Co Ltd's Operating Income forecast?
Projected CAGR
25%
For the last 4 years the compound annual growth rate for Giant Biogene Holding Co Ltd's operating income is 30%. The projected CAGR for the next 3 years is 25%.
What is Giant Biogene Holding Co Ltd's Net Income forecast?
Projected CAGR
26%
For the last 4 years the compound annual growth rate for Giant Biogene Holding Co Ltd's net income is 26%. The projected CAGR for the next 3 years is 26%.
You don't have any saved screeners yet
